Source link : https://www.newshealth.biz/health-news/fda-adds-guillain-barre-syndrome-warning-to-two-rsv-vaccines/
The FDA issued a safety communication that warns about possible Guillain-Barré syndrome (GBS) with respiratory syncytial virus (RSV) vaccines manufactured by Pfizer (Abrysvo) and GSK (Arexvy). The prescribing information for each vaccine has been revised to say that a postmarketing observational study suggested an increased risk of GBS in the 42 days following vaccination. GBS […]
Author : News Health
Publish date : 2025-01-08 14:33:00
Copyright for syndicated content belongs to the linked Source.